Microbiology & virology data management
Data pipelines built to reconcile central lab microbiology, virology, and susceptibility results with clinical response endpoints, supporting time-to-clinical-cure and eradication analyses.
Why anti-infective & vaccine sponsors choose us
Built for lab-coordinated, regulator-facing data
Three ways an integrated Biometrics and Clinical Operations model changes how an anti-infective or vaccine program runs.
Biostatistics for anti-infective & vaccine trials
Statistical support spanning non-inferiority designs for antimicrobials and immunogenicity/efficacy analyses for vaccines, including seroconversion rate, GMT ratio, and reactogenicity endpoints.
Reactogenicity & AEFI safety reporting
Clinical Operations builds solicited and unsolicited adverse event reporting workflows scoped to vaccine reactogenicity diaries and AEFI regulatory expectations.
Common questions
Before you scope an anti-infective or vaccine study
Running an anti-infective or vaccine program?
Tell us your indication, phase, and lab partners — we'll map a Biometrics and Clinical Operations model built for lab-coordinated data.